Agomab Therapeutics raised €83M in a Series D+ round in Oct 2024. The company is based in Ghent, Belgium. Investors in the round: Asabys Partners, Invus, Sanofi. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
